一个可穿戴的节奏振动器装置的前性受控研究,用于帕金森病中的震
F Goltz1, M F Dirkx1, J M Schoffelen2
1Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands; Radboud University Medical centre, Department of Neurology, Centre of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands.
概括
周围振动刺激 (ViS) 在帕金森病 (PD) 患者中没有显著降低力. 这项研究发现,在不同类型的震和认知负载中,没有对震幅度或阶段的调节.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 往往会抵抗多巴胺作用药物,需要替代治疗.
- 周围 afferent刺激显示了减轻震的潜力,但证据有限,缺乏严格的控制.
- 研究PD震的新型非药物干预措施至关重要.
研究的目的:
- 评估开放循环外周振动刺激 (ViS) 在调节帕金森病 (PD) 中震的疗效.
- 评估ViS对各种条件下的客观震指标的影响,包括休息和姿势震.
- 为了确定震动和刺激是否可以使用相锁定值 (PLV) 同步 (引入).
主要方法:
- 30名患有明显震的PD患者参加了受试者内部对照研究.
- 开放循环ViS在四个条件下应用于手腕:震动频率,1.5x震动频率,80 Hz和假.
- 在休息震,认知负载和姿势震任务期间测量了震功率 (加速度计) 和引力 (PLV).
主要成果:
- 在任何ViS条件下都没有观察到震动强度的显著降低.
- 在不同震情境 (休息,认知负载,姿势) 中,ViS对震的影响没有变化.
- 阶段锁定值分析表明,震动和应用的ViS之间没有拖动.
结论:
- 开放循环振动刺激在调节帕金森病震方面是无效的.
- 这项受控研究提供了强有力的证据反对ViS作为PD震的治疗方法.
- 进一步的研究可能会探索闭环刺激或不同的刺激参数.
相关概念视频
Parkinson's Disease: Treatment
185
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
185
Parkinson's Disease: Overview
424
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
424


